Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (331-340 of 415) with videos related to

Pageof 42
Sort By:
Cancer Immunology, Immunotherapy : CII|April 4, 2014
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaEster Simeone, Giusy Gentilcore, Diana Giannarelli, et al.
Clinical Colorectal Cancer|March 19, 2023
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA TrialDebora Basile, Gerardo Rosati, Francesca Bergamo, et al.
Journal of Translational Medicine|May 18, 2018
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world settingChiara Mandoj, Laura Pizzuti, Domenico Sergi, et al.
Journal of Cancer|March 10, 2016
Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer PatientsPatrizia Vici, Laura Pizzuti, Luigi Di Lauro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2020
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort studyLuana Lionetto, Martina Ulivieri, Matilde Capi, et al.
Breast Cancer Research and Treatment|September 20, 2014
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER studyPatrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Journal of Cellular Physiology|May 26, 2017
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancerLaura Pizzuti, Domenico Sergi, Chiara Mandoj, et al.
The Oncologist|January 26, 2026
Clinical characteristics and Drug-Drug interactions in HER2+ breast cancer treated with T-DXd: Real-World data from the DE-REAL studySimona Pisegna, Simone Scagnoli, Gabriella Gentile, et al.
Tumori|October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statementStefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Pancreas|May 18, 2018
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter AnalysisOronzo Brunetti, Giuseppe Aprile, Paolo Marchetti, et al.
Pageof 42

Showing results (331-340 of 415) with videos related to

Sort By:
Pageof 42
Cancer Immunology, Immunotherapy : CII|April 4, 2014
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaEster Simeone, Giusy Gentilcore, Diana Giannarelli, et al.
Clinical Colorectal Cancer|March 19, 2023
Prognostic Value of Body Mass Index in Stage II/III Colon Cancer: Posthoc Analysis From the TOSCA TrialDebora Basile, Gerardo Rosati, Francesca Bergamo, et al.
Journal of Translational Medicine|May 18, 2018
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world settingChiara Mandoj, Laura Pizzuti, Domenico Sergi, et al.
Journal of Cancer|March 10, 2016
Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer PatientsPatrizia Vici, Laura Pizzuti, Luigi Di Lauro, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 18, 2020
Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort studyLuana Lionetto, Martina Ulivieri, Matilde Capi, et al.
Breast Cancer Research and Treatment|September 20, 2014
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER studyPatrizia Vici, Laura Pizzuti, Clara Natoli, et al.
Journal of Cellular Physiology|May 26, 2017
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancerLaura Pizzuti, Domenico Sergi, Chiara Mandoj, et al.
The Oncologist|January 26, 2026
Clinical characteristics and Drug-Drug interactions in HER2+ breast cancer treated with T-DXd: Real-World data from the DE-REAL studySimona Pisegna, Simone Scagnoli, Gabriella Gentile, et al.
Tumori|October 30, 2016
Ethics in oncology: principles and responsibilities declared in the Italian Ragusa statementStefania Gori, Carmine Pinto, Caterina Caminiti, et al.
Pancreas|May 18, 2018
Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter AnalysisOronzo Brunetti, Giuseppe Aprile, Paolo Marchetti, et al.
Pageof 42